NUCLEOLIN and brain cancer: The expression of NCL in endothelial and perivascular cells such as astrocytes and pericytes within the NVU of the human fetal brain, its downregulation in the adult healthy brain and reactivation in brain tumors characterizes NCL as an oncofetal protein and suggests an integral role once reactivated during brain cancer.